Age (Median) | 50 years |
---|---|
range | (23–72) |
Stage | |
I | 8 (6.8) |
II | 54 (45.8) |
III | 26 (22.0) |
Metastatic | 8 (6.8) |
Bilateral Breast Ca | 3 (2.5) |
Axillary Lymph node | |
Positive | 42 (35.6) |
Negative | 29 (24.6) |
Data missing | 47 (39.8) |
Estrogen Receptor | |
Positive | 22(18.6) |
Negative | 35 (29.7) |
Data missing | 61 (51.7) |
Progestorone Receptor | |
Positive | 19 (16.1) |
Negative | 37 (31.4) |
Data missing | 62 (52.5) |
Surgery | |
Breast conservation | 6 (5.1) |
Mastectomy | 90 (76.3) |
Chemotherapy | |
FAC | 44 (51.2) |
CMF | 42 (48.8) |
Radiotherapy | 50 (42.4) |